![Cui Ling Wu](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Cui Ling Wu
Presidente en
Guangzhou Fulengen Co., Ltd.
.
Perfil
En la actualidad, Cui Ling Wu ocupa el cargo de Presidente del Consejo de Supervisión de Guangzhou Wondfo Biotech Co., Ltd. y Presidente de Guangzhou Fulengen Co., Ltd. Ltd. También forma parte del consejo de Da An Gene Co., Ltd. de la Universidad Sun Yat-sen, y es subdirectora del Centro Farmacéutico Biotecnológico de Guangzhou y profesora de la Universidad Sun Yat-Sen. Se licenció en la Universidad Farmacéutica de Guangdong.
Cargos activos de Cui Ling Wu
| Empresas | Cargo | Inicio |
|---|---|---|
Sun Yat-Sen University
 Sun Yat-Sen University Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | 09/03/2010 |
Guangzhou Bio-tech Pharmaceuticals Center | Corporate Officer/Principal | 01/03/2001 |
Guangzhou Fulengen Co., Ltd.
 Guangzhou Fulengen Co., Ltd. Guangzhou Fulengen Co., Ltd. is a biotechnology and life science research company specializing in genome editing tools, gene function research, and molecular biology products. The company is based in Guangzhou, China. The Chinese company develops and promotes a broad portfolio of products, including full-length cDNA and ORF expression clones, recombinant proteins, RNA interference tools (shRNA, miRNA), custom cloning services, and gene editing technologies such as CRISPR-Cas9 and TALEN. Fulengen offers genome editing solutions encompassing Cas9 proteins, sgRNA libraries, stable cell lines, validation systems, and gene knock-in kits, supporting gene editing research workflows. The company also provides miRNA research tools, qPCR reagents and arrays for gene and miRNA expression profiling, viral vector systems for gene delivery, and nucleic acid virus detection kits for pandemic-related research. Fulengen collaborates with international research institutions and biotech companies, contributing to human genome projects and developing protein expression databases. | Presidente | - |
Antiguos cargos conocidos de Cui Ling Wu.
| Empresas | Cargo | Fin |
|---|---|---|
| DAAN GENE CO., LTD. | Director/Miembro de la Junta | 27/05/2022 |
| GUANGZHOU WONDFO BIOTECH CO.,LTD | Presidente | - |
Formación de Cui Ling Wu.
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
77
Relaciones de 1er grado
6
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas privadas | 6 |
|---|---|
Daan Gene Co., Ltd.
 Daan Gene Co., Ltd. BiotechnologyHealth Technology Manufactures and distributes molecular biology based reagents & medical equipment | Health Technology |
Guangzhou Bio-tech Pharmaceuticals Center | |
Guangzhou Wondfo Biotech Co., Ltd.
 Guangzhou Wondfo Biotech Co., Ltd. BiotechnologyHealth Technology Engages in the manufacture, sale of biochemical reagents, medical products and diagnostic test kits | Health Technology |
Sun Yat-Sen University
Sun Yat-Sen University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Guangdong Pharmaceutical University
 Guangdong Pharmaceutical University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Guangzhou Fulengen Co., Ltd.
Guangzhou Fulengen Co., Ltd. Guangzhou Fulengen Co., Ltd. is a biotechnology and life science research company specializing in genome editing tools, gene function research, and molecular biology products. The company is based in Guangzhou, China. The Chinese company develops and promotes a broad portfolio of products, including full-length cDNA and ORF expression clones, recombinant proteins, RNA interference tools (shRNA, miRNA), custom cloning services, and gene editing technologies such as CRISPR-Cas9 and TALEN. Fulengen offers genome editing solutions encompassing Cas9 proteins, sgRNA libraries, stable cell lines, validation systems, and gene knock-in kits, supporting gene editing research workflows. The company also provides miRNA research tools, qPCR reagents and arrays for gene and miRNA expression profiling, viral vector systems for gene delivery, and nucleic acid virus detection kits for pandemic-related research. Fulengen collaborates with international research institutions and biotech companies, contributing to human genome projects and developing protein expression databases. |
- Bolsa de valores
- Insiders
- Cui Ling Wu
